Imaging subclinical atherosclerosis promises better cardiovascular primary prevention

Abstract

Get full access to this article

View all access options for this article.

References

Piepoli

Hoes

Agewall

et al.

2016 European Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J 2016; 37: 2315–2381.

Arnett DK, Blumenthal RS, Albert MA, et al. 2019 ACC/AHA Guideline on the primary prevention of cardiovascular disease: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. Epub ahead of print 17 March 2019. DOI: 10.1016/j.jacc.2019.03.010.

Jørstad

Colkesen

Boekholdt

et al.

Estimated 10-year cardiovascular mortality seriously underestimates overall cardiovascular risk. Heart 2016; 102: 63–68.

Faggiano P, Dasseni N, Gaibazzi N, et al. Cardiac calcification as a marker of subclinical atherosclerosis and predictor of cardiovascular events: A review of the evidence. Eur J Prev Cardiol. 2019; 26: 1191–1204.

Otto

Lind

Kitzman

et al.

Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly. N Engl J Med 1999; 341: 142–147.

Tamar

Polonsky

McClelland

et al.

Coronary artery calcium score and risk classification for coronary heart disease prediction. JAMA 2010; 303: 1610–1616.

Bittencourt

Blankstein

Blaha

et al.

Implications of coronary artery calcium testing on risk stratification for lipid-lowering therapy according to the 2016 European Society of Cardiology recommendations: The MESA study. Eur J Prev Cardiol 2018; 25: 1887–1898.

Mortensen

Fuster

Muntendam

et al.

A simple disease-guided approach to personalize ACC/AHA-recommended statin allocation in elderly people. The BioImage Study. J Am Coll Cardiol 2016; 68: 881–891.

Tokgozoglu

Bruckert

. Implementation, target population, compliance and barriers to risk guided therapy. Eur J Prev Cardiol 2012; 19: 37–41.

10.

Ludt

Wensing

Campbell

et al.

The challenge of cardiovascular prevention in primary care: Implications of a European observational study in 8928 patients at different risk levels. Eur J Prev Cardiol 2014; 21: 203–213.

11.

Clarke

Kurmi

et al.

Burden of carotid artery atherosclerosis in Chinese adults: Implications for future risk of cardiovascular diseases. Eur J Prev Cardiol 2017; 24: 647–656.

12.

Näslund

Lundgren

et al.

Visualization of asymptomatic atherosclerotic disease for optimum cardiovascular prevention (VIPVIZA): A pragmatic, open-label, randomised controlled trial. Lancet 2019; 393: 133–142.

13.

Denissen SJAM, van der Aalst CM, Vonder M, et al. Impact of a cardiovascular disease risk screening result on preventive behavior in asymptomatic participants of the ROBINSCA trial. Eur J Prev Cardiol 2019; 26: 1313–1322.